Cannabis Laws in Ireland

Ireland has taken cautious steps toward medical cannabis access through its Medical Cannabis Access Programme (MCAP), which became operational in 2019 following years of campaigning by patient advocates and their families. The program is notably restrictive, limited to just three qualifying conditions: spasticity associated with multiple sclerosis, intractable nausea and vomiting associated with chemotherapy, and severe treatment-resistant epilepsy. Access requires a prescription from a medical consultant (not a general practitioner), and patient numbers have remained low due to the narrow eligibility criteria, limited product availability, and the complexity of the prescribing process.

Recreational cannabis remains illegal in Ireland, with possession for personal use treated as a criminal offense. A 2019 working group recommended considering alternatives to prosecution for personal possession, including a health-led approach, but legislative change has been slow. Ireland's CBD market has grown significantly, with products below 0.2% THC widely available in health food stores, pharmacies, and online retailers. The Irish market is notable for strong consumer interest in CBD wellness products. Politically, cannabis reform has gained some support, with a Citizens' Assembly on Drug Use recommending decriminalization of personal possession in 2023, adding momentum to reform efforts.